[ad_1] Top line New research based on early-stage clinical trials shows promising, but conflicting results for Sinovac Biotech’s CoronaVac Covid-19 vaccine, which is capable of generating a “rapid” immune response in individuals but has produced lower than those recorded in people who had recovered from Covid-19. Sinovac Biotech reported Phase …
Read More »Sinovac’s Covid-19 vaccine appears safe and requires a ‘rapid’ immune response, according to study
